How Colorectal Cancer Differs in Younger Adults

March is Colorectal Cancer Awareness Month. New research from Cleveland Clinic shows how the tumor microbiome in younger adults appears to be different.

Translate to Spanish or other 102 languages!

He said they are not entirely sure, but it could be possible that the way colorectal cancer develops in younger adults is driven by a different group of microorganisms.  Image for illustration purposes
He said they are not entirely sure, but it could be possible that the way colorectal cancer develops in younger adults is driven by a different group of microorganisms.  Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – March is Colorectal Cancer Awareness Month, and reports show the number of cases among younger adults is rising. 

It’s unclear exactly why that is, but research from Cleveland Clinic could help shed some light. 

“What we analyzed in our recent research was looking at the cancers that came from younger people and cancers that occurred in older people, and we found that the microbiome of younger onset colorectal cancer is actually different than the microbiome of older onset colorectal cancer,” said Alok Khorana, MD, oncologist for Cleveland Clinic who led the research.

- Advertisement -

Dr. Khorana said the microbiome of a tumor is made up of human and non-human cells, and in this study, they found there was more bacteria in the tumor microbiome of younger adults with colorectal cancer. 

So, why is that? 

He said they are not entirely sure, but it could be possible that the way colorectal cancer develops in younger adults is driven by a different group of microorganisms. 

“So, this really leads us to search for more clues as to why this is happening. Is it related to diet? Is it related to environment? Is it related to antibiotic use in younger people? Is it related to exposures of babies, children, or adolescents? We don’t fully understand that. This is another step in trying to figure out what is happening,” said Dr. Khorana.

- Advertisement -

Dr. Khorana said the hope from this research is that it can ultimately aid in colorectal cancer prevention and treatment options in the future. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -